This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Lenalidomide Sandoz is indicated for use in several critical haematology-oncology conditions, per latest ESMO guidelines
The Vasostrict brand market had U.S. sales of approximately US $ 878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
A total of 12 generic medicines have been included in the list
Subscribe To Our Newsletter & Stay Updated
